New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access Is Easy. Choosing the Right ETF Is Not

With 1,790 launches through July 2026, finding an ETF is easy and choosing one is not. 46% of share classes hold under $50 million, and nearly 7 in 10 allocators are reassessing their holdings, with portfolio fit the top criterion. See how 620 professionals select ETFs.

Access the report

›ETF Issuers›J.P. Morgan Asset Management›JRDE

JRDE

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF

Dist

EUR

Active ETF Equity ESG

Not rated

The JRDE Exchange Traded Fund (ETF) is provided by J.P. Morgan Asset Management. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

£4,257.75

+£14 (+0.32%) yesterday

7:00 AM 10/16/26 Closed

1D price range

£4,247.00£4,257.75

52W price range

£3,851.00£4,980.95

YTD Perf.

+11.09%

YTD Flows

Annualized volatility

Fund AuM

€2.99B

Share class AuM

€120M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

IE000WGK3YY5

TER

0.2503%

Inception date

9/22/2021

Issuer

J.P. Morgan Asset Management

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
JERE JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF	+2.33%
EXSC iShares STOXX Europe Large 200 UCITS ETF (DE)	+2.34%
SMEA iShares Core MSCI Europe UCITS ETF (Acc)	+2.38%
BBEU JPMorgan BetaBuilders Europe ETF	+2.06%
EEUE BNP Paribas Easy MSCI Europe Min TE UCITS ETF	+1.13%
IEV iShares Europe ETF	+2.05%
EL42 Deka MSCI Europe UCITS ETF	+1.18%
IEU iShares Europe ETF (AU)	+2.95%
DBEU Xtrackers MSCI Europe Hedged Equity ETF	+2.24%
MEU Amundi MSCI Europe UCITS ETF	+2.38%
10AI Amundi Core MSCI Europe UCITS ETF	+2.38%
ERO State Street SPDR MSCI Europe UCITS ETF	+2.38%
EURD UBS Core MSCI Europe UCITS ETF	+2.32%
HMES HSBC MSCI EUROPE UCITS ETF	+2.38%
DX2I Xtrackers MSCI Europe Screened UCITS ETF	+2.28%

API

PerformanceDec 31, 2025 - Oct 15, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 08/31/26

Finance

25.48%

Industrials

16.92%

Healthcare

12.16%

Technology

11.47%

Consumer Non-Cyclicals

8.17%

Non-Energy Materials

5.83%

Utilities

5.19%

Energy

4.94%

Unavailable

0.75%

Other

9.08%

Latest JRDE news

No content available for this fund

FAQ about JRDE

JRDE is a Active ETF. This ETF provides exposure to Other Large and Mid-Cap European Equities.

JRDE carries a total expense ratio (TER) of 0.2503%, indicating the annual cost for holding the fund.

JRDE was introduced to the market on September 22, 2021. It trades on Norway, among other exchanges

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF, JRDE, is provided by J.P. Morgan Asset Management. Learn more about J.P. Morgan Asset Management here.

Yes, JRDE is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

JRDE oversees €120M in assets as of October 15, 2026.

JRDE follows a distributing dividend policy, meaning it pays out income to investors. As of October 15, 2026, its 12-month trailing yield was 2.52%.

As of August 31, 2026, JRDE has significant geographic allocations in United Kingdom, France and Germany.

As of August 31, 2026, JRDE focuses largely on Finance, Industrials and Healthcare.

As of August 31, 2026, JRDE holds 153 positions in its portfolio, with 31.20% of assets concentrated in its top 15 holdings.

As of August 31, 2026, JRDE top three holdings include ASML Holding NV, Siemens AG and HSBC Holdings Plc.

The base currency of JRDE is EUR.

Top 10 holdings

Data as of 08/31/26

ASML Holding NV

5.04%

Siemens AG

2.39%

HSBC Holdings Plc

2.33%

Allianz SE

2.23%

AstraZeneca PLC

2.06%

Nestlé SA

2.01%

Roche Holding AG

1.96%

Shell Plc

1.95%

Banco Santander SA

1.88%

Novartis AG

1.87%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Access Is Easy. Choosing the Right ETF Is Not

JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF

FAQ about JRDE

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US